Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Nov 15, 2003; 9(11): 2592-2595
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2592
Table 1 Patient data
Characteristicsn
Number of patients67
Male38
Female29
Median age (y)
Male50.68
Female48.60
Disease categories
Cirrhotic ascites36
Tuberculous ascites8
Malignant ascites23
Ovarian cancer8
Gastric cancer6
Colon cancer5
Hepatocellular cancer2
Pancreatic cancer1
Primary peritoneal carcinoma1
Table 2 Qualitative analysis of type IV collagenase activity in various kinds of ascites
Ascites typeMMP-2 (Positive cases)MMP-9 (Positive cases)
Cirrhotic ascites00
Tuberculous ascites00
Malignant ascites2018
Gastric cancer55
Colon cancer35
Hepatocellular cancer21
Pancreatic cancer10
Ovarian cancer86
Primary peritoneal carcinoma11
Table 3 Semi-quantitative analysis of MMP-2, MMP-9 activity in different kinds of malignant ascites
TypeCase (n)MMP-2 activity (n)
MMP-9 activity (n)
+/-1+2++/-1+2+
Gastric cancer6140320
Colon cancer5120410
Hepatocellular cancer2110010
Pancreatic cancer1010000
Ovarian cancer8152312
Primary peritoneal carcinoma1001001
Table 4 Comparison of detection of type IV collagenase and other indexes in malignant ascites
Type IV collagenase
LDH in ascites/serum LDH (> 1: positive)CytologicexaminationSerum complex indexes (AFP, CEA, CA)
MMP-2MMP-9
Positive numbers2018101113
Positive rates87.0%78.3%43.4%47.8%56.5%